Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cruzado, J. M.
Right arrow Articles by Grinyo, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cruzado, J. M.
Right arrow Articles by Grinyo, J. M.

Journal of the American Society of Nephrology, Vol 7, 2469-2475, Copyright © 1996 by American Society of Nephrology


REGULAR ARTICLES

Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts

JM Cruzado, S Gil-Vernet, G Ercilla, D Seron, M Carrera, J Bas, J Torras, J Alsina and JM Grinyo
Department of Nephrology, Ciutat Sanitaria i Universitaria de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

In renal transplantation, chronic allograft nephropathy is the leading cause of long-term graft losses, transplant glomerulopathy being its glomerular form. Differential diagnosis from recurrent or de novo membranoproliferative glomerulonephritis should be established. Whether hepatitis C virus is associated with cryoglobulinemia and glomerular damage in renal allograft recipients, as in native kidneys, is not known. We identified six hepatitis C virus-infected renal allograft recipients with proteinuria higher than 1.5 g/day, microhematuria, and membranoproliferative glomerulonephritis. Virologic and immunologic studies were conducted. Low serum levels of circulating immune complexes and cryoglobulins were observed, which were type II immunoglobulin G polyclonal-immunoglobulin Mk monoclonal in all six patients. Classical serum complement pathway activation and at least one type of autoantibodies were present in all of them. Hepatitis C virus RNA was found in higher concentrations in cryoprecipitate than in serum (percentage of enrichment ranged from 341 to 18,200%). Hepatitis C virus genotype was 1b in 4 of 6 patients, 1a in 1 of 6 patients, and 2a in 1 of 6 patients. In renal histology prominent parietal diffuse deposition of immunoglobulin M was the rule. Glomerular subendothelial electron-dense deposits with fibrillar appearance were observed in the two patients in which electron microscopy provided information about glomeruli. In renal allograft recipients hepatitis C virus infection may be associated with type II cryoglobulinemia which may lead to membranoproliferative glomerulonephritis. Immunologic and virologic studies may help to differentiate hepatitis C virus-associated membranoproliferative glomerulonephritis from transplant glomerulopathy.


This article has been cited by other articles:


Home page
CJASNHome page
N. A. Terrault and D. B. Adey
The Kidney Transplant Recipient with Hepatitis C Infection: Pre- and Posttransplantation Treatment
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 563 - 575.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Bestard, J. M. Cruzado, G. Ercilla, M. Goma, J. Torras, D. Seron, I. Rama, M. Ibernon, O. Vinas, M. Carrera, et al.
Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2320 - 2324.
[Full Text] [PDF]


Home page
CJASNHome page
A. Djamali, M. Samaniego, B. Muth, R. Muehrer, R. M. Hofmann, J. Pirsch, A. Howard, G. Mourad, and B. N. Becker
Medical Care of Kidney Transplant Recipients after the First Posttransplant Year
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 623 - 640.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. M. Cruzado, E. M. Briganti, R. C. Atkins, S. J. Chadban, and the Australia and New Zealand Dialysis and Transpl
Recurrent Glomerulonephritis and Risk of Renal Allograft Loss
N. Engl. J. Med., November 7, 2002; 347(19): 1531 - 1532.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
J. Am. Soc. Nephrol., October 1, 2000; 11(2007): S1 - S86.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. M. MORALES and J. M. CAMPISTOL
Transplantation in the Patient with Hepatitis C
J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1343 - 1353.
[Full Text]


Home page
Nephrol Dial TransplantHome page
M. A. Gentil, J. L. Rocha, G. Rodriguez-Algarra, P. Pereira, R. Lopez, G. Bernal, J. Munoz, M. Naranjo, and J. Mateos
Impaired kidney transplant survival in patients with antibodies to hepatitis C virus
Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2455 - 2460.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. M. Cruzado, J. Torras, J. Dominguez, C. Sancho, J. Alsina, and J. M. Grinyo
An unusual cause of post-biopsy oliguria in an allograft
Nephrol. Dial. Transplant., August 1, 1999; 14(8): 2022 - 2024.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. BAID, M. PASCUAL, W. W. WILLIAMS JR., N. TOLKOFF-RUBIN, S. M. JOHNSON, B. COLLINS, R. T. CHUNG, F. L. DELMONICO, A. B. COSIMI, and R. B. COLVIN
Renal Thrombotic Microangiopathy Associated with Anticardiolipin Antibodies in Hepatitis C-Positive Renal Allograft Recipients
J. Am. Soc. Nephrol., January 1, 1999; 10(1): 146 - 153.
[Abstract] [Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP